Delighted to contribute to @ACCinTouch’s review of the ATOMIC trial.
Combined chemo + ICI regimens create new opportunities in cancer care, but also new CV considerations.
Grateful to @Vijayrao7474 @nsdamera @GIMedOnc for their insights & collaboration!
acc.org/latest-in-card…
Combined chemo + ICI regimens create new opportunities in cancer care, but also new CV considerations.
Grateful to @Vijayrao7474 @nsdamera @GIMedOnc for their insights & collaboration!
acc.org/latest-in-card…